Kidney Biopsy Market Research Report‚Äď Forecast till 2030

Kidney Biopsy Market Research Report: By Type (Percutaneous and Surgical Biopsy), Indication (Hematuria, Kidney Failure, Proteinuria, Kidney Transplant), End User (Hospitals & Clinics, Tertiary Care Centers, Urology Centers)-Forecast till 2030

ID: MRFR/MED/3867-HCR | 110 Pages | Published By Kinjoll Dey on March 2023         

Kidney Biopsy Market Speak to Analyst Request a Free Sample

Kidney Biopsy Market Overview

The kidney biopsy market is anticipated to grow at a substantial speed in the years to come. The renal biopsy market is anticipated to reach USD 2,893.32 Million by 2030 at 5.2% CAGR during the forecast period 2022-2030. The market is expected to grow due to increased biopsy operations and a rise in demand for novel techniques for diagnosing chronic illnesses. Furthermore, the market is likely to develop as the frequency of renal conditions rises and the need for improved diagnostic and treatment approaches.


A kidney biopsy, also called a renal biopsy, is a technique that involves extracting a sample of kidney tissue for testing. Kidney biopsy is used to identify kidney illness, track treatment progress, and see if the kidney transplant operates well. Percutaneous biopsy and surgical biopsy are the two most common forms. A needle is put into the kidney via the skin in a percutaneous biopsy. In contrast, an incision is done in the skin around the kidney to obtain a tissue sample for evaluation in a surgical biopsy.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The renal biopsy market saw a slight downfall post the pandemic due to the lockdown and physical distancing.


However, the key companies have adopted measures to expand the distribution of renal biopsy equipment globally. Moreover, people are growing aware of kidney disorders, and renal biopsy procedures are increasing. Hence, these factors are expected to boost the kidney biopsy market value in the years to come.


Market Dynamics


Drivers


A few factors may drive the growth of the kidney biopsy market share. The market is growing because of an increase in biopsy operations and the demand for novel techniques for diagnosing chronic illnesses.


Opportunities


The major key companies of the kidney biopsy market are adopting various trends such as new product launches with advanced technology for diagnosis and treatment. Established market companies in rich nations drive globalization by providing new goods and services to more contemporary countries while emerging economies offer the renal biopsy market opportunities to grow.


Restraints


There are a few factors that may inhibit the kidney biopsy market growth. One of the most important of them is the high cost of the procedures. Renal failures and related illnesses have a high treatment and management cost. The lack of infrastructure in the healthcare sectors of low and middle-income countries may also hinder the market growth in the long run.


Challenges


There are various concerns with the market that may challenge the key players of the market. This includes the cost of the diagnosis and treatment solutions. High treatment and maintenance costs for renal failures and related illnesses and a lack of infrastructure in medium and low-income nations may limit the expansion of the kidney biopsy market forecast.


Cumulative Growth Analysis


The kidney biopsy market is anticipated to grow at a substantial speed in the years to come. The renal biopsy market value is expected to grow at a CAGR of about 5.2%. The market is expected to grow due to increased biopsy operations and a rise in demand for novel techniques for diagnosing chronic illnesses. Furthermore, the market is likely to develop as the frequency of renal diseases rises and the need for improved diagnostic and treatment approaches.


Value Chain Analysis


Kidney illness is commonly referred to be a "silent disease" since it has no symptoms in its early stages and might go unnoticed, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic kidney disease (CKD) is a worldwide health problem and a risk factor for heart disease (CVD). The major causes of CKD include high blood pressure and diabetes.


The kidney biopsy market is expected to develop due to increased biopsy operations and a rise in demand for novel techniques for diagnosing chronic illnesses. Furthermore, the market is expected to create as the frequency of renal diseases rises and the need for improved diagnostic and treatment approaches. Globalization is being led by established market actors in rich nations, selling new products and services to developing and emerging economies. The high cost of diagnostic services, on the other hand, may limit market expansion throughout the projection period.


Segment Overview


The global kidney biopsy market is classified into many segments such as type, indication, and end-user. Listed below are the renal biopsy market segments:


By Type



  • Percutaneous biopsy

  • Surgical biopsy


By Indication



  • Kidney failure

  • Kidney transplant

  • Hematuria

  • Proteinuria

  • Others


By End-user



  • Hospitals & clinics

  • Urology centers

  • Tertiary care centers

  • Others


Regional Analysis


The regional division of the kidney biopsy market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. The increasing use of technically advanced medical equipment to identify and treat kidney disease, government funding for research and development, and increased healthcare expenditure drive the renal biopsy market in the Americas. Also, the market is being fueled by an increase in the number of patients with kidney disease, diabetes, and other risk factors for renal failure.


Europe is the second biggest market for kidney biopsy, with growth due to a growing focus on developing innovative diagnostic equipment in urology, expanding government funding for R&D, and the availability of research funds. The market's growth is additionally accelerated by the increasing number of specialist services supplied by various healthcare providers in Europe. Throughout the projection period, favorable reimbursement policies, greater use, and considerable expenditures in developing new technologies for treating illnesses will drive market expansion.


Because of the rising incidence of diabetes and the increasing number of kidney transplant operations in urology clinics, Asia Pacific is the fastest expanding kidney biopsy market. The market is also driven by the rapidly growing healthcare technology industry and rising healthcare spending. Furthermore, rising demand for high-quality medical devices is likely to lead to increased utilization of innovative equipment, accelerating market expansion in this area.


Competitive Landscape


The kidney biopsy industry is dominated by a few companies that play a vital role in the market growth. These renal biopsy equipment and service provider companies are called key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting kidney biopsy market trends such as joint ventures, product launches, company expansions, and procurements. They provide innovative solutions for patients suffering from various renal disorders.


Key Players


Below are the key companies that offer kidney disorder diagnosis and treatment solutions in the global market, with the location of their headquarters:



  • Boston Scientific Corporation (U.S.)

  • Integra LifeSciences Corporation (U.S.)

  • Argon Medical Devices Inc. (U.S.)

  • Cook Medical (U.S.)

  • Hologic Inc. (U.S.)

  • Creganna (U.S.)

  • Scion Medical Technologies LLC (U.S.)

  • Devicor Medical Products Inc. (U.S.)

  • Intact Medical Corporation (U.S.)

  • Focal Therapeutics, Inc. (U.S.)

  • C R Bard Inc. (U.S.)

  • CareFusion (U.S.)

  • Precision Biopsy, LLC (U.S.)


Recent Developments



  • Spring-loaded automated "biopsy" weapons have recently been used in percutaneous¬†kidney biopsy¬†to reduce its time to get a sample. A local anesthetic is administered to the patient. For kidney biopsies in children and adolescents, this is a preferred method.


Report Overview


This report delivers all the information about the global kidney biopsy market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected market outlook.


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 2,893.32 Million
  CAGR   2022-2030: 5.2%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, indication, and end user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boston Scientific Corporation (U.S.), Cook Medical (U.S.), C R Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), Hologic Inc. (U.S.), Intact Medical Corporation (U.S.), Precision Biopsy, LLC (U.S.), Scion Medical Technologies LLC (U.S.), Integra LifeSciences Corporation (U.S.), Creganna (U.S.), Focal Therapeutics, Inc. (U.S.), CareFusion (U.S.), Argon Medical Devices, Inc. (U.S.) and others
  Key Market Opportunities   Established market players in the developed countries lead the globalization by offering new products and services to the developing countries and emerging economies
  Key Market Drivers

  • Increasing number of biopsy procedures
  • Rising demand for new techniques for diagnosis of chronic diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The kidney biopsy market would grow with 5.2% during the forecast period.

    High cost of diagnostic tools can deter the kidney biopsy market.

    The end users in the kidney biopsy market are tertiary care centers, urology centers, hospitals & clinics, and others.

    The dominating kidney biospy market region is the Americas.

    The second-largest kidney biopsy market is Europe.